Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 3
2010 2
2011 3
2012 4
2013 5
2014 8
2015 6
2016 2
2017 6
2018 4
2019 5
2020 2
2021 5
2022 4
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma.
Riscal R, Bull CJ, Mesaros C, Finan JM, Carens M, Ho ES, Xu JP, Godfrey J, Brennan P, Johansson M, Purdue MP, Chanock SJ, Mariosa D, Timpson NJ, Vincent EE, Keith B, Blair IA, Skuli N, Simon MC. Riscal R, et al. Among authors: skuli n. Cancer Discov. 2021 Dec 1;11(12):3106-3125. doi: 10.1158/2159-8290.CD-21-0211. Cancer Discov. 2021. PMID: 34244212 Free PMC article.
The Bad, the Good and eIF3e/INT6.
Sesen J, Casaos J, Scotland SJ, Seva C, Eisinger-Mathason TS, Skuli N. Sesen J, et al. Among authors: skuli n. Front Biosci (Landmark Ed). 2017 Jan 1;22(1):1-20. doi: 10.2741/4469. Front Biosci (Landmark Ed). 2017. PMID: 27814599 Free article. Review.
Metformin and Cancer, an Ambiguanidous Relationship.
Skuli SJ, Alomari S, Gaitsch H, Bakayoko A, Skuli N, Tyler BM. Skuli SJ, et al. Among authors: skuli n. Pharmaceuticals (Basel). 2022 May 19;15(5):626. doi: 10.3390/ph15050626. Pharmaceuticals (Basel). 2022. PMID: 35631452 Free PMC article. Review.
Even Cancer Cells Watch Their Cholesterol!
Riscal R, Skuli N, Simon MC. Riscal R, et al. Among authors: skuli n. Mol Cell. 2019 Oct 17;76(2):220-231. doi: 10.1016/j.molcel.2019.09.008. Epub 2019 Oct 2. Mol Cell. 2019. PMID: 31586545 Free PMC article. Review.
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
Casaos J, Gorelick NL, Huq S, Choi J, Xia Y, Serra R, Felder R, Lott T, Kast RE, Suk I, Brem H, Tyler B, Skuli N. Casaos J, et al. Among authors: skuli n. Mol Cancer Ther. 2019 Jul;18(7):1185-1194. doi: 10.1158/1535-7163.MCT-18-0666. Mol Cancer Ther. 2019. PMID: 31263027 Review.
Nuclear speckles regulate HIF-2α programs and correlate with patient survival in kidney cancer.
Alexander KA, Yu R, Skuli N, Coffey NJ, Nguyen S, Faunce C, Huang H, Dardani IP, Good AL, Lim J, Li C, Biddle N, Joyce EF, Raj A, Lee D, Keith B, Simon MC, Berger SL. Alexander KA, et al. Among authors: skuli n. bioRxiv [Preprint]. 2023 Sep 16:2023.09.14.557228. doi: 10.1101/2023.09.14.557228. bioRxiv. 2023. PMID: 37745397 Free PMC article. Preprint.
Bile acid metabolism mediates cholesterol homeostasis and promotes tumorigenesis in clear cell renal cell carcinoma.
Riscal R, Gardner SM, Coffey NJ, Carens M, Mesaros C, Xu JP, Xue Y, Davis L, Demczyszyn S, Vogt A, Olia A, Finan JM, Godfrey J, Schultz DC, Blair IA, Keith B, Marmorstein R, Skuli N, Simon MC. Riscal R, et al. Among authors: skuli n. Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-0821. Online ahead of print. Cancer Res. 2024. PMID: 38417134
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.
Malric L, Monferran S, Gilhodes J, Boyrie S, Dahan P, Skuli N, Sesen J, Filleron T, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A. Malric L, et al. Among authors: skuli n. Oncotarget. 2017 Aug 21;8(49):86947-86968. doi: 10.18632/oncotarget.20372. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156849 Free PMC article. Review.
61 results